Bio-XCell

Home > Business & Industry > Bio-XCell

Malaysia's premier dedicated custom-built biotechnology park, Bio-XCell, is Malaysia's first dedicated biotechnology park. It was unveiled at BIO Atlanta in 2009 and officially launched at the BIO International Convention in Chicago in May 2010. Located on approximately 160 acres of prime industrial land in SiLC Nusajaya, Bio-XCell is a joint venture between Biotechnology Corporation Malaysia and UEM Sunrise Berhad.

Malaysia's premier dedicated custom-built biotechnology park, Bio-XCell, is Malaysia's first dedicated biotechnology park.

Bio-XCell is a biotechnology ecosystem and park offering customisation to directly meet investors' requirements. Set up at a development cost of RM1 billion, the park is built around strategic anchor tenants and offers 'platinum building' i.e. customised buildings built to tenants' requirements and 4,000-sq-ft built-up standard shell facilities for companies to lease.

Tenants will also benefit from clustered and shared facilities such as the Central Hub and Central Utilities Facility (CUF). The Central Hub or CenHub, will house shared facilities such as administrative offices, research and development laboratories, logistics and meeting facilities. The CUF is a central storage system where chilled water, steam and gas – specific to the biotechnology industry – would be distributed to biotech companies in the biotech park. The construction of the Central Hub commenced in 2010 and upon completion was launched in December 2012.

On board at Bio-XCell are Strides Arcolab and Biocon Ltd – India's first billion-dollar technology company, Metex of France and Glycos Inc. of the United States. Biocon invested RM500 million to establish a bio-manufacturing and R&D facility for insulin products to focus on research and development as well as production of high-rise biosimilars and other biopharmaceutical products. The facility is planned to be operational in 2014.

Metex is planning to produce palm derivative oil at an investment value of RM120 million while Glycos biotechnology is investing RM46 million to produce a higher-grade biodegradable ethanol. Both investors will build their facilities to produce intermediate and final bio-based products that involve bacteria fermentation processes.

For more information, kindly visit: www.bio-xcell.my